Close menu




October 5th, 2020 | 10:42 CEST

TubeSolar, Blackrock Gold and FCR Real Estate: money makes the world go round

  • Investments
Photo credits: pixabay.com

Filled company coffers open up many opportunities to seize growth opportunities. From a timing point of view, capital increases or new investments are therefore often interesting. Which companies are now sitting on high level liquidity that can be invested profitably, or who will soon receive new funds? Here are three companies that investors should take a closer look at right now.

time to read: 2 minutes | Author: Carsten Mainitz
ISIN: CA09258M1014 , DE000A2PXQD4 , DE000A1YC913

Table of contents:


    TubeSolar AG - AgroPhotovoltaic play with a lot of potential

    The share certificates of TubeSolar AG have only been listed since February 14. The Augsburg-based company is a spin-off of the laboratory production including patents of OSRAM/LEDVANC. TubeSolar has been manufacturing photovoltaic thin-film tubes that are assembled into modules since 2019. These thin-film tubes for solar energy generation have considerable advantages over silicon solar modules, for example in terms of weight, geometry, material usage, and yield.

    The technology is to be used primarily in the agricultural sector (agro-photovoltaics) and span agricultural production areas. In the next few years, it is expected to expand production in Augsburg to an annual production capacity of 250 MW.

    TubeSolar AG has announced that it is aiming for a capital increase with subscription rights and a listing on the m:access of the Munich Stock Exchange.

    The company plans to put a production facility with a capacity of 20 MW into operation in the fiscal year 2021. For this purpose, the Free State of Bavaria will grant the company an investment subsidy of up to EUR 10.8 million. This exciting company currently has a market capitalization of EUR 83.5 million.

    Blackrock Gold Corp - Waiting for the next price boost

    Blackrock Gold is an exploration company focused on the discovery of gold and silver deposits in the State of Nevada. Nevada, also known as the "Silver State", is one of the best mining jurisdictions in the world.

    At the beginning of June, the stock started a rapid upward movement, which led from CAD 0.30 to almost CAD 1.60 within a very short time. Extensive investment commitments of CAD 12 million, including CAD 5 million from industry icon Eric Sprott, were the reasons for this. The share is currently quoted at CAD 0.90 and is valued at around CAD 100 million. With its coffers full, the company has now increased the 2020 exploration program to identify high-grade zones. Four targets have been defined on the Tonopah project.

    The Silver Cloud project, as the company recently announced, will most likely be spun off into a separate exploration company. The company's management is currently considering that Blackrock shareholders will receive one SpinCo share for every three shares held. The market is now waiting for approval.

    It is only a matter of time before the share price will increase as a result of new drill results. The spin-off of the Silver Cloud project will also have a positive effect.

    FCR Immobilien AG - Capital increase and change to the regulated market planned

    FCR Immobilien, listed on m:access, intends to carry out a capital increase and is also planning a segment change from scale to regulated trading. FCR reported that it has "adopted a comprehensive package of measures for the planned growth of the company."

    A securities prospectus, for the short-term implementation of the segment change, and the capital increase, was submitted to BaFin. Further details of KE are not yet available. The funds received from the planned cash capital increase, with subscription rights for existing shareholders and public offering, are to be used to expand the real estate portfolio. FCR intends to expand its real estate portfolio from over EUR 300 million by a further EUR 160 million.

    FCR is a specialized investor for shopping and specialty shopping centers in Germany, focusing on promising secondary locations that offer above-average yield potential due to their location. FCR also invests opportunistically in the asset classes: office, residential, and logistics. The company has set a target of EUR 11.1 million in earnings before taxes for the current fiscal year. The share is thus favorably valued.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read